153 related articles for article (PubMed ID: 11850065)
21. Ontogeny of G-protein expression: control by beta-adrenoceptors.
Zeiders JL; Seidler FJ; Slotkin TA
Brain Res Dev Brain Res; 2000 Apr; 120(2):125-34. PubMed ID: 10775765
[TBL] [Abstract][Full Text] [Related]
22. Regulation of adenylyl cyclase by noradrenaline and tumour necrosis factor alpha in rat cardiomyocytes.
Reithmann C; Gierschik P; Jakobs KH; Werdan K
Eur Heart J; 1991 Dec; 12 Suppl F():139-42. PubMed ID: 1666552
[TBL] [Abstract][Full Text] [Related]
23. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
24. Hypersensitivity of Gi protein mediated muscarinic receptor adenylyl cyclase in chronic ischaemic heart failure in the rat.
Fu LX; Feng QP; Liang QM; Sun XY; Hedner T; Hoebeke J; Hjalmarson A
Cardiovasc Res; 1993 Nov; 27(11):2065-70. PubMed ID: 8287419
[TBL] [Abstract][Full Text] [Related]
25. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling.
Insel PA; Ostrom RS
Cell Mol Neurobiol; 2003 Jun; 23(3):305-14. PubMed ID: 12825829
[TBL] [Abstract][Full Text] [Related]
26. Effect of sulpiride on somatostatin receptors, somatostatin-like immunoreactivity and modulation of adenylyl cyclase activity in the rat brain.
Rodriguez-Sanchez MN; Boyano-Adánez MC; Puebla L; Rodriguez-Henche N; Guijarro LG; Prieto JC; Arilla E
Neuropharmacology; 1994 Jun; 33(6):745-54. PubMed ID: 7936112
[TBL] [Abstract][Full Text] [Related]
27. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
28. Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle.
Tobise K; Ishikawa Y; Holmer SR; Im MJ; Newell JB; Yoshie H; Fujita M; Susannie EE; Homcy CJ
Circ Res; 1994 Apr; 74(4):596-603. PubMed ID: 8137496
[TBL] [Abstract][Full Text] [Related]
29. Beta-adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization.
Giannuzzi CE; Seidler FJ; Slotkin TA
Brain Res; 1995 Oct; 694(1-2):271-8. PubMed ID: 8974654
[TBL] [Abstract][Full Text] [Related]
30. Developmental changes in Gs and G(olf) proteins and adenylyl cyclases in mouse brain membranes.
Rius RA; Mollner S; Pfeuffer T; Loh YP
Brain Res; 1994 Apr; 643(1-2):50-8. PubMed ID: 8032932
[TBL] [Abstract][Full Text] [Related]
31. G proteins, adenylyl cyclase and related phosphoproteins in the developing rat heart.
Bartel S; Karczewski P; Krause EG
Mol Cell Biochem; 1996; 163-164():31-8. PubMed ID: 8974037
[TBL] [Abstract][Full Text] [Related]
32. Adenylyl cyclase signal transduction and alcohol-induced sedation.
Froehlich JC; Wand GS
Pharmacol Biochem Behav; 1997 Dec; 58(4):1021-30. PubMed ID: 9408209
[TBL] [Abstract][Full Text] [Related]
33. Prolonged Morphine Treatment Alters Expression and Plasma Membrane Distribution of β-Adrenergic Receptors and Some Other Components of Their Signaling System in Rat Cerebral Cortex.
Hejnova L; Skrabalova J; Novotny J
J Mol Neurosci; 2017 Dec; 63(3-4):364-376. PubMed ID: 29081032
[TBL] [Abstract][Full Text] [Related]
34. Differences in type II, IV, V and VI adenylyl cyclase isoform expression between rat preadipocytes and adipocytes.
Serazin-Leroy V; Morot M; de Mazancourt P; Giudicelli Y
Biochim Biophys Acta; 2001 Nov; 1550(1):37-51. PubMed ID: 11738086
[TBL] [Abstract][Full Text] [Related]
35. Early alterations in the brown adipose tissue adenylate cyclase system of pre-obese Zucker rat fa/fa pups: decreased G-proteins and beta 3-adrenoceptor activities.
Charon C; Krief S; Diot-Dupuy F; Strosberg AD; Emorine LJ; Bazin R
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):781-8. PubMed ID: 8554520
[TBL] [Abstract][Full Text] [Related]
36. Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
García-Jiménez A; Cowburn RF; Ohm TG; Bogdanovic N; Winblad B; Fastbom J
Brain Res; 1999 Dec; 850(1-2):104-17. PubMed ID: 10629754
[TBL] [Abstract][Full Text] [Related]
37. Receptor crosstalk: effects of prolonged carbachol exposure on beta 1-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes.
Paraschos A; Karliner JS
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):267-76. PubMed ID: 7824043
[TBL] [Abstract][Full Text] [Related]
38. G-proteins in experimental hypertension: a study of spontaneously hypertensive rat myocardial and renal cortical plasma membranes.
McLellan AR; Milligan G; Houslay MD; Connell JM
J Hypertens; 1993 Apr; 11(4):365-72. PubMed ID: 8390503
[TBL] [Abstract][Full Text] [Related]
39. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.
O'Neill C; Wiehager B; Fowler CJ; Ravid R; Winblad B; Cowburn RF
Brain Res; 1994 Feb; 636(2):193-201. PubMed ID: 8012802
[TBL] [Abstract][Full Text] [Related]
40. Forskolin binding sites and G-protein immunoreactivity in rat hearts during aging.
Shu Y; Scarpace PJ
J Cardiovasc Pharmacol; 1994 Feb; 23(2):188-93. PubMed ID: 7511746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
